InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (23 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
23
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Butchko Julia G., Directrice du Développement et de la Technologie. Officer active across 1 company, notably Immunovant, Inc.. Cumulatively, 27 disclosures have been logged. Breakdown: 0 buy · 23 sells. Total volume traded: €1.4m. History available since 3 August 2021. The latest transaction was disclosed on 21 August 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Butchko Julia G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
2,907 shares@ US$31.844.6% of flowCommon StockSEC:0001764013-24-000157:0
2,698 shares@ US$29.644.1% of flowCommon StockSEC:0001764013-24-000134:0
1,527 shares@ US$28.062.2% of flowCommon StockSEC:0001764013-24-000126:0
3,247 shares@ US$29.655.0% of flowCommon StockSEC:0001764013-24-000097:0
7,825 shares@ US$28.8011.8% of flowCommon StockSEC:0001764013-24-000077:0
1,053 shares@ US$31.181.7% of flowCommon StockSEC:0001764013-24-000071:0
54,978 shares0Common StockSEC:0001764013-24-000048:0
2,146 shares@ US$36.154.0% of flowCommon StockSEC:0001764013-24-000038:0
1,297 shares@ US$38.592.5% of flowCommon StockSEC:0001764013-24-000007:0
3,141 shares@ US$32.755.3% of flowCommon StockSEC:0001764013-23-000141:0
296 shares@ US$35.540.6% of flowCommon StockSEC:0001764013-23-000118:0
12,332 shares@ US$20.3012.9% of flowCommon StockSEC:0001764013-23-000101:0
1,470 shares@ US$19.731.5% of flowCommon StockSEC:0001764013-23-000077:0
1,544 shares@ US$15.271.2% of flowCommon StockSEC:0001764013-23-000051:0
100,188 shares0Common StockSEC:0001764013-23-000042:0
19 shares@ US$15.160.0% of flowCommon StockSEC:0001764013-23-000010:0
928 shares@ US$9.180.5% of flowCommon StockSEC:0001764013-22-000132:0
535 shares@ US$4.670.1% of flowCommon StockSEC:0001764013-22-000124:0
548 shares@ US$5.830.2% of flowCommon StockSEC:0001764013-22-000111:0
112,816 shares0Common StockSEC:0001764013-22-000103:0
510 shares@ US$4.270.1% of flowCommon StockSEC:0001764013-22-000078:0
460 shares@ US$4.020.0000% mcap0.2% of flowCommon StockSEC:0001764013-22-000071:0
492 shares@ US$3.790.1% of flowCommon StockSEC:0001764013-22-000047:0
541 shares@ US$4.720.2% of flowCommon StockSEC:0001764013-22-000043:0
6,381 shares@ US$5.902.4% of flowCommon StockSEC:0001764013-22-000037:0
25 of 27 declarations
About Butchko Julia G.
Butchko Julia G. is Chief Development Officer. She has 27 filings in total, and across the sampled recent filings between 2021-08-04 and 2024-08-23 for Immunovant, Inc. (XNAS), the transactions are sales totaling EUR 1439050, with a modal transaction nature of sell.
